Nurse Anesthetist - CR in Arkansas City, KS Accepting Medicare

3 Nurse Anesthetist - CR nurses found. Showing 1 - 3

Theresa A Sutton, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 216 West Birch, Sckrmc, Arkansas City, KS 67005 Phone: 620-442-2500    Fax: 620-441-5968

Jessica Hope Linaweaver, NURSE ANESTHETIST Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 6401 Patterson Pkwy, Arkansas City, KS 67005 Phone: 620-441-5798

Mr. Kasey W Thrailkill, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 6401 Patterson Pkwy, Arkansas City, KS 67005 Phone: 620-441-5798

News Archive

Thermo Fisher Scientific collaborates with CGT Catapult to create seamless cell and gene therapy supply chain

To help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with the Cell and Gene Therapy Catapult to provide developers with both the manufacturing capability and distribution, logistics, and storage capacity needed to create a seamless supply chain to accelerate cell and gene therapy development and commercialsation.

First Edition: July 22, 2010

Today's headlines reflect news about health reform implementation activities, health information technology and sparring opinions about the Massachusetts experience.

Earwax removal - new guidelines

The American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) will issue the first comprehensive clinical guidelines to help health care practitioners identify patients with cerumen (commonly referred to as earwax) impaction. The guidelines emphasize evidence-based management of cerumen impaction by clinicians, and inform patients of the purpose of ear wax in hearing health.

BMS amends and extends MJN common stock exchange offer

Bristol-Myers Squibb Company and Mead Johnson Nutrition Company today announced that Bristol-Myers Squibb Company ("BMS") has amended and extended its offer to exchange up to 170.0 million shares of common stock of Mead Johnson Nutrition Company ("MJN") for outstanding shares of BMS common stock that are validly tendered and not validly withdrawn at an exchange ratio determined by a formula described in a registration statement filed by MJN on Form S-4 (Reg No. 333-163126).

Researchers develop new way to identify potential therapeutic targets for drug resistant melanoma

Moffitt Cancer Center researchers developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.

Read more Medical News

› Verified 6 days ago